| Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion F Li, S Kitajima, S Kohno, A Yoshida, S Tange, S Sasaki, N Okada, ... Cancer Research 79 (15), 3903-3915, 2019 | 76 | 2019 |
| The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity S Kitajima, A Yoshida, S Kohno, F Li, S Suzuki, N Nagatani, Y Nishimoto, ... Oncogene 36 (36), 5145-5157, 2017 | 57 | 2017 |
| ATM mediates pRB function to control DNMT1 protein stability and DNA methylation A Shamma, M Suzuki, N Hayashi, M Kobayashi, N Sasaki, T Nishiuchi, ... Molecular and Cellular Biology, 2013 | 53 | 2013 |
| The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain Y Soeda, H Tsuneki, H Muranaka, N Mori, S Hosoh, Y Ichihara, S Kagawa, ... Molecular endocrinology 24 (10), 1965-1977, 2010 | 48 | 2010 |
| Involvement of prokineticin 2–expressing neutrophil infiltration in 5-fluorouracil–induced aggravation of breast cancer metastasis to lung S Sasaki, T Baba, H Muranaka, Y Tanabe, C Takahashi, S Matsugo, ... Molecular cancer therapeutics 17 (7), 1515-1525, 2018 | 38 | 2018 |
| Undifferentiated state induced by Rb-p53 double inactivation in mouse thyroid neuroendocrine cells and embryonic fibroblasts S Kitajima, S Kohno, A Kondoh, N Sasaki, Y Nishimoto, F Li, ... Stem Cells 33 (5), 1657-1669, 2015 | 33 | 2015 |
| A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling H Muranaka, A Hayashi, K Minami, S Kitajima, S Kohno, Y Nishimoto, ... Oncogenesis 6 (6), e350-e350, 2017 | 31 | 2017 |
| Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repair S Li, T Yokota, P Wang, J Ten Hoeve, F Ma, TM Le, ER Abt, Y Zhou, R Wu, ... The Journal of Clinical Investigation 132 (2), 2022 | 21 | 2022 |
| MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6 A Yoshida, S Kitajima, F Li, C Cheng, Y Takegami, S Kohno, YS Wan, ... Oncotarget 8 (8), 13872, 2017 | 16 | 2017 |
| An in vitro system to characterize prostate cancer progression identified signaling required for self‐renewal M Salah, Y Nishimoto, S Kohno, A Kondoh, S Kitajima, H Muranaka, ... Molecular Carcinogenesis 55 (12), 1974-1989, 2016 | 9 | 2016 |
| NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism N Okada, C Ueki, M Shimazaki, G Tsujimoto, S Kohno, H Muranaka, ... Communications Biology 6 (1), 596, 2023 | 7 | 2023 |
| Plasma metabolomics predicts chemotherapy response in advanced pancreatic cancer H Muranaka, A Hendifar, A Osipov, N Moshayedi, V Placencio-Hickok, ... Cancers 15 (11), 3020, 2023 | 6 | 2023 |
| Gut microbiome and pancreatic cancer cachexia: an evolving relationship A Hendifar, R Akinsola, H Muranaka, A Osipov, S Thomassian, ... World Journal of Gastrointestinal Oncology 14 (7), 1218, 2022 | 5 | 2022 |
| Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner L Zhang, S Billet, G Gonzales, K Rohena-Rivera, H Muranaka, GCY Chu, ... Cancers 14 (14), 3449, 2022 | 4 | 2022 |
| Peripubertal high‐fat diet promotes c‐Myc stabilization in mammary gland epithelium N Kulathunga, S Kohno, P Linn, Y Nishimoto, S Horike, MI Zaraiskii, ... Cancer Science 111 (7), 2336-2348, 2020 | 4 | 2020 |
| Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol J Gong, A Osipov, J Lorber, M Tighiouart, AK Kwan, H Muranaka, ... Biomedicines 11 (5), 1392, 2023 | 3 | 2023 |
| NFYA promotes the malignant behavior of triple-negative breast cancer through the regulation of lipid metabolism N Okada, C Ueki, M Shimazaki, G Tsujimoto, S Kohno, H Muranaka, ... bioRxiv, 2022.05. 26.493660, 2022 | 2 | 2022 |
| Abstract LB-130: The metabolic function of RB tumor suppressor gene. S Kohno, S Kitajima, N Sasaki, H Muranaka, C Takahashi Cancer Research 73 (8_Supplement), LB-130-LB-130, 2013 | 2 | 2013 |
| Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention H Muranaka, R Akinsola, S Billet, SJ Pandol, AE Hendifar, NA Bhowmick, ... Cancers 16 (5), 1057, 2024 | 1 | 2024 |
| Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivity H Muranaka, S Billet, C Cruz-Hernández, J Ten Hoeve, G Gonzales, ... | 1 | 2023 |
